Biopharma News : Biopharma and Pharma news from all around the world :
- NICE and the SMC Have Published Recommendations on Shionogi’s Mulpleo® (Lusutrombopag), Approving Its Use for the Treatment of Severe Thrombocytopenia in Adult Patients With Chronic Liver Disease Undergoing Invasive Procedures
- Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer Symposium
- NantHealth Presents Research Demonstrating Real World Evidence of Simultaneous Presentation and Publication of Oncology Data at the 2019 San Antonio Breast Cancer Symposium
- Zoetis Declares First Quarter 2020 Dividend; Board Approves 22% Payment Increase
- Intersect ENT to Present at the 38th Annual J.P. Morgan Healthcare Conference
- Kite Submits Biologics License Application to U.S. Food and Drug Administration for Company’s Second CAR T Cell Therapy
- Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results
- Biocom Expresses Strong Concerns Over New USMCA Agreement Removing Essential Protections for Life-Saving Drugs
- Global Kidney Cancer Drugs Market Report 2020: Focus on Nexavar, Sutent, Afinitor, Votrient, Avastin, Inlyta, Torisel, Proleukin – ResearchAndMarkets.com
- New Study from Naturally Slim Demonstrates Effectiveness of Ongoing Employer-Sponsored Weight Loss Programs
- Global Gastric Cancer Drugs Market Report 2020: Focus on Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab – ResearchAndMarkets.com
- Global Ovarian Cancer Drugs Market Report 2020: Focus on Epithelial Ovarian Cancer, Ovarian Low Malignant Potential Tumour, Germ Cell Tumour, Sex Cord-Stromal Tumour – ResearchAndMarkets.com
- Global Anesthetics Market Report 2020 with Profiles of Key Players – Baxter, Abbott Laboratories, AstraZeneca, F. Hoffmann-La Roche AG, B. Braun Melsungen – ResearchAndMarkets.com
- Global Prostate Cancer Drugs Market Report 2020 – ResearchAndMarkets.com
- Global Thyroid Cancer Drugs Market Report 2020: Focus on Ipilimumab, Cabozantinib-S-Malate, Caprelsa, Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib – ResearchAndMarkets.com
- Invicro Supports the Alzheimer’s Disease Neuroimaging Initiative
- Global Monoclonal Antibodies (mAbs) Market Report 2020 with Profiles of Johnson & Johnson, Merck, AbbVie, Amgen, Glaxosmithkline – ResearchAndMarkets.com
- Managed Healthcare Executive® Releases Results of Annual 2019 State of the Industry Survey
- Global Bladder Cancer Drugs Market Report 2020: Focus on Non-Muscle-Invasive Bladder Cancer & Muscle-Invasive Bladder Cancer – ResearchAndMarkets.com
- Global Blood Cancer Drugs Market Report 2020: Focus on Rituaxan/Mabthera, Gleevac/Glivec, Revlimid, Velcade, Tasigna, Pomalyst, Vidaza, Kyprolis Adcetris – ResearchAndMarkets.com
- Seattle Genetics Announces Positive Tucatinib HER2CLIMB Trial Results in Locally Advanced or Metastatic HER2-Positive Breast Cancer Presented at 2019 SABCS and Published in the New England Journal of Medicine
- Global Brain Tumor Drugs Market Report 2020: Focus on Temozolomide, Carmustine, Cisplatin, Bevacizumab, Geftinib, Erlotinib – ResearchAndMarkets.com
- Global Cervical Cancer Drugs Market Report 2020: Market was Valued $15.3 Billion in 2018 and is Expected to Grow to $17.9 billion Through 2022 – ResearchAndMarkets.com
- GenEdit and Editas Medicine Enter into Exclusive License and Collaboration Agreement for Nanoparticle Gene Therapy Delivery
- Fresenius Kabi Expands Anti-Infective Portfolio with Launch of Ertapenem for Injection in 1 Gram Vial Presentation
- Genovis Launches Immobilized SialEXO® for Efficient Biopharmaceutical Sample Preparation
- BioUtah and the University of Utah’s Center for Technology & Venture Commercialization Announce Early Bird Registration for the 2020 Entrepreneur and Investor Summit
- Fully-human BCMA CAR-T Clinical Results for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by IASO BIO and Innovent Presented at the 2019 ASH Annual Meeting
- Moderna Announces Key 2020 Investor and Analyst Events
- Tilray® Receives Additional GMP Certification at EU Campus Allowing for International Export of Finished Medical Cannabis Products
Biotech – Biopharma News!
- MagForce AG: ‘NanoTherm School’ successfully enters its second round with Module B
- Biotest AG: Biotest AG opens fourth plasma collection centre in Czech Republic
- ADC Therapeutics Announces Oral Presentation of Interim Efficacy Data from Pivotal Phase 2 Clinical Trial of ADCT-402 (Loncastuximab Tesirine) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma at 61st ASH Annual Meeting
- Medartis provides update on Brazil investigation
- AEVIS VICTORIA SA: Sale of Générale Beaulieu Immobilière SA to Infracore SA
- Apogenix to Present New Data on Asunercept at ESMO Immuno-Oncology Congress
- New hope for brain tumor patients in Saxony: Paracelsus Clinic Zwickau and MagForce AG open new NanoTherm therapy center for the East German region
- Biotest AG: Biotest AG increases Guidance
- Medgate Deutschland established – RHÖN KLINIKUM AG and Medgate sign foundation agreement
- MOLOGEN AG: Insolvency Filing
- EVOTEC EXPANDS STRATEGIC PARTNERSHIP WITH CELMATIX IN WOMEN’S HEALTH
- Original-Research: Expedeon AG (von GBC AG)
- MOLOGEN AG: Update on short-term financing of the Company
- Epigenomics AG: Epigenomics AG Reports on New Micro-Simulation Study Results Published in Cancer Medicine Indicating That Epi proColon Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer
- B.R.A.I.N. Biotechnology Research And Information Network AG: New Chairman of the Management Board – Adriaan Moelker takes over from Dr Jürgen Eck
- Epigenomics AG: New Micro-Simulation Study in Cancer Medicine Finds Epi proColon(R) Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer
- Original-Research: MagForce AG (von GBC AG)
- Vivoryon Therapeutics AG: Vivoryon Therapeutics Reports Third Quarter 2019
- Vivoryon Therapeutics AG: Vivoryon Therapeutics attends CTAD 2019
- AEVIS VICTORIA SA: Development of the hotel segment
- DiaMonTech AG postpones IPO
- Xlife Sciences AG: Xlife Sciences AG: Xlife Sciences AG issues convertible bonds
- DiaMonTech AG: DAK-Gesundheit and DiaMonTech plan strategic cooperation in the non-invasive blood glucose monitoring sector for new treatment strategies in the diabetes sector
- Xlife Sciences AG: FUSE-AI, a project company of Xlife Sciences AG enters cooperation agreement with Aarau Cantonal Hospital
- Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)
- Biofrontera AG: Biofrontera to Participate in Upcoming Investor Conferences
- MOLOGEN AG: Issuance of a convertible bond with exclusion of shareholders’ subscription rights
- HAEMATO AG: IFRS Third-Quarter 2019 Results
- CO.DON AG: CO.DON nominated by US magazine ‘MedTech Outlook’ for ‘TOP 10 Orthopedic Solution Providers in Europe 2019’
- CO.DON AG: CO.DON nominated by US magazine ‘MedTech Outlook’ for ‘TOP 10 Orthopedic Solution Providers in Europe 2019’
- Tonix Pharmaceuticals Announces New European Patent for the Composition and Formulation of TNX-102 SL
- miRagen Announces Major Changes to Company’s Strategy
- PDS Biotechnology Announces Resignation of James Loughlin from Board of Directors
- Assembly Biosciences Announces Proposed Public Offering of Common Stock
- Forty Seven, Inc. Announces Proposed Underwritten Public Offering of Common Stock
- Pixium Vision’s 2020 financial calendar
- Corrected Press Release: Marinus Pharmaceuticals Announces Pricing of $65 Million Public Offering of Common Stock and Concurrent Private Placement
- Kiadis Pharma announces change to management board
- MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San Antonio Breast Cancer Symposium
- Terranueva Obtains a $2 Million Revolving Credit and Updates
- BioSyent Announces Renewal of Normal Course Issuer Bid
- PMV Pharma Appoints Leila Alland, M.D., as Chief Medical Officer
- HMS Supports Dallas-based CitySquare’s Efforts to Fight Poverty and Address Social Determinants of Health
- Daré Bioscience Announces Alignment with the FDA on Phase 2b Study Design and Novel Primary Endpoint PRO Instruments to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
- RAPT Therapeutics Reports Third Quarter 2019 Financial Results and Recent Highlights
- Coloplast A/S – Trading in Coloplast shares by board members, executives or associated persons
- Madrigal Pharmaceuticals Announces Pricing of Secondary Offering
- Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock
- CES Innovation Honoree Cubii Debuts Cubii Go Compact Elliptical at 2020 Consumer Electronics Show
- Bone Bank Allografts Announces Partnership with Yankee Alliance
- OrthoPediatrics Corp. Announces Proposed Public Offering of Common Stock
- Marinus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
- Iterum Therapeutics Announces Topline Results from Phase 3 Clinical Trial of Oral and IV Sulopenem for the Treatment of Complicated Intra-abdominal Infections
- Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock
- Madrigal Pharmaceuticals Announces Secondary Offering of 1,200,000 Shares of Common Stock
- Diffusion Pharmaceuticals Presents Data Suggesting Optimized TSC Dosing Regimen Increases Survival in Newly Diagnosed Inoperable Glioblastoma Patients
- Monthly information regarding the total number of voting rights and total number of shares of the Company
- Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market
- Financial calendar for Zealand Pharma in 2020
- Admera Health Announces Appointment of Omar Karame as Chief Financial Officer
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News